Development and validation of a cost-utility model for Type 1 diabetes mellitus.
about
Cost-effectiveness of switching to insulin degludec from other basal insulins: evidence from Swedish real-world data.The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus.Projected long-term outcomes in patients with type 1 diabetes treated with fast-acting insulin aspart vs conventional insulin aspart in the UK setting.A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes Mellitus.Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial
P2860
Development and validation of a cost-utility model for Type 1 diabetes mellitus.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Development and validation of a cost-utility model for Type 1 diabetes mellitus.
@en
type
label
Development and validation of a cost-utility model for Type 1 diabetes mellitus.
@en
prefLabel
Development and validation of a cost-utility model for Type 1 diabetes mellitus.
@en
P2093
P2860
P356
P1433
P1476
Development and validation of a cost-utility model for Type 1 diabetes mellitus.
@en
P2093
P2860
P304
P356
10.1111/DME.12663
P577
2015-02-13T00:00:00Z